Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 9, 2026

8 hours ago

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Indeterminate GlobeNewswire

8 hours ago

Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo

Indeterminate GlobeNewswire

8 hours ago

NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program

Indeterminate GlobeNewswire

8 hours ago

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

Indeterminate GlobeNewswire

8 hours ago

Aktis Oncology to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Indeterminate GlobeNewswire

8 hours ago

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

8 hours ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

8 hours ago

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Indeterminate GlobeNewswire

8 hours ago

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Indeterminate GlobeNewswire

8 hours ago

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire

8 hours ago

MBX Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS

Indeterminate GlobeNewswire

8 hours ago

SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer

Indeterminate GlobeNewswire

8 hours ago

Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

8 hours ago

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

Indeterminate GlobeNewswire

8 hours ago

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

9 hours ago

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Indeterminate GlobeNewswire

9 hours ago

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

9 hours ago

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Indeterminate GlobeNewswire